Skip to main content
. 2011 Mar 24;25(6):933–943. doi: 10.1210/me.2010-0486

Table 1.

SXR down-regulation in lymphatic tumors (Oncomine)

Study Cancer type Cancer n Control tissue Control expression Control n Median SXR expression P value
Zhan myeloma 3 Monoclonal Gam. of Und. Sig. 44 Bone marrow −0.072 22 −0.353 4.76 × 10−5
Andersson leukemia B cell acute lymphoblastic leukemia 87 Bone marrow 0.341 6 −1.106 2.34 × 10−4
Basso lymphoma Burkitt's lymphoma 17 B lymphocytes 0.11 5 −0.204 0.02
Basso lymphoma Primary effusion 9 B lymphocytes 0.11 5 −0.346 0.032
Basso lymphoma Centroblastic lymphoma 28 B lymphocytes 0.11 5 −0.226 0.035
Basso lymphoma Hairy cell leukemia 16 B lymphocytes 0.11 5 −0.207 0.043
Andersson leukemia T cell acute lymphoblastic leukemia 11 Bone marrow 0.341 6 −0.412 0.065
Zhan myeloma 3 Smoldering lymphoma 12 Bone marrow −0.072 12 −0.431 0.091
Basso lymphoma Diffuse large B cell lymphoma 32 B lymphocytes 0.11 5 −0.169 0.101
Basso lymphoma Mantle cell lymphoma 8 B lymphocytes 0.11 5 −0.157 0.152
Haslinger leukemia CLL 100 B lymphocytes 0.322 11 0.084 0.189
Stegmaier leukemia Acute myeloid leukemia 9 Monocytes −0.614 3 −0.761 0.192

SXR expression data from selected microarray studies deposited in Oncomine.